US Bronchitis Treatment Market 2020 Analysis May Set New Growth Story, Forecast to 2026

US bronchitis treatment market is projected to grow at a significant CAGR of around 2.4% during the forecast period (2020-2026). The market for bronchitis treatment in India is driven by the rising incidence and mortality rate of bronchitis in the country. According to the Centers for Disease Control and Prevention (CDC), in the US states with the highest, mortality rate from the chronic lower respiratory disease are West Virginia (64.3%), Oklahoma (63.5%), Kentucky (62.1%), Arkansas (61.7%), and Mississippi (59.9%). Though, the highest mortalities were registered in California (13,634 mortalities with 30.9% mortality rate), Florida (12,362 mortalities with 37.0% mortality rate), Texas (10,766 mortalities with 39.7% mortality rate), Ohio (7,518 mortalities with 49.0% mortality rate), and New York (7,270 mortalities with 28.5% mortality rate).
• Number of adults with diagnosed chronic bronchitis in 2018: 9.0 million
• Percent of adults with diagnosed chronic bronchitis in 2018: 3.6%
Bronchitis (chronic and unspecified) mortalities
• Number of mortalities: 492
• Deaths per 100,000 population: 0.2

To Request a Sample of our Report on US Bronchitis Treatment Market: https://www.omrglobal.com/request-sample/us-bronchitis-treatment-market

There are several research organizations in the US that are engaged in the development of effective treatment solution for the chronic lung disorders. Bronchitis is one among the major lung disease that is being studied in the healthcare research organization in the country. Along with the research organizations, there are several market players headquartered in the US, such as Abbott Laboratories and Pfizer Inc.

(Get 15% Discount on Buying this Report)
A full Report of US Bronchitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/us-bronchitis-treatment-market

US Bronchitis Treatment Market – Segmentation

By Technology
• Medication
• Antibiotics
• Anti-inflammatory drugs
• Bronchodilators
• Others (Mucolytics)
• Oxygen Therapy

Company Profiles

• Abbott Laboratories
• Aurobindo Pharma Ltd.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• Dr Reddy's Laboratories Ltd.
• GlaxoSmithKline PLC
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-bronchitis-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.